1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Orthobiologics Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Orthobiologics Market, Ireland 7
3.1 Orthobiologics Market, Ireland, Revenue ($m), 2008-2015 7
3.2 Orthobiologics Market, Ireland, Revenue ($m), 2015-2022 9
3.2.1 Bone Grafts and Substitutes Market, Ireland, Revenue ($m), by Segment, 2008-2015 11
3.2.2 Bone Grafts and Substitutes Market, Ireland, Revenue ($m), by Segment, 2015-2022 13
3.3 Orthobiologics Market, Ireland, Volume (Units), 2008-2015 15
3.4 Orthobiologics Market, Ireland, Volume (Units), 2015-2022 17
3.4.1 Bone Grafts and Substitutes Market, Ireland, Volume (Units), by Segment, 2008-2015 19
3.4.2 Bone Grafts and Substitutes Market, Ireland, Volume (Units), by Segment, 2015-2022 21
3.5 Orthobiologics Market, Ireland, Average Price ($), 2008-2015 23
3.6 Orthobiologics Market, Ireland, Average Price ($), by Segment 2008-2015 25
3.7 Orthobiologics Market, Ireland, Distribution Share by Revenue ($m), 2008-2022 27
3.8 Orthobiologics Market, Ireland, Company Share by Revenue ($m), 2015 28
4 Overview of Key Companies in Ireland, Orthobiologics Market 30
4.1 Medtronic plc 30
4.1.1 Company Overview 30
4.2 DePuy Synthes, Inc. 30
4.2.1 Company Overview 30
4.3 Baxter International Inc. 30
4.3.1 Company Overview 30
4.4 Sanofi 31
4.4.1 Company Overview 31
4.5 Arthrex, Inc. 31
4.5.1 Company Overview 31
4.6 DJO Finance LLC 31
4.6.1 Company Overview 31
4.7 Bioventus LLC 32
4.7.1 Company Overview 32
4.8 Ossatec Benelux B.V. 32
4.8.1 Company Overview 32
4.9 Stryker Corporation 32
4.9.1 Company Overview 32
4.10 Patterson Medical Holdings, Inc. 32
4.10.1 Company Overview 32
4.11 Mylan N.V. 33
4.11.1 Company Overview 33
5 Orthobiologics Market Pipeline Products 34
6 Recent Developments 37
6.1 Corporate Communications 37
6.1.1 May 04, 2016: Medtronic Welcomes Karen L. Parkhill as Its New Chief Financial Officer 37
6.1.2 Mar 17, 2016: Medtronic Proposes Proxy Access 38
6.2 Financial Announcements 38
6.2.1 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 38
6.2.2 Mar 01, 2016: Medtronic Reports Third Quarter Financial Results 41
6.2.3 Feb 19, 2016: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2016 43
6.2.4 Sep 03, 2015: Medtronic Reports First Quarter Financial Results 43
6.3 Legal And Regulatory 46
6.3.1 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 46
6.3.2 Nov 20, 2015: Medtronic Statement on U.S. Department of Treasury’s Notice 2015-79 46
6.4 Other Significant Developments 47
6.4.1 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 47
6.4.2 Apr 06, 2016: Medtronic Statement on U.S. Department of Treasury’s Recent Temporary and Proposed Regulations 47
6.4.3 Dec 14, 2015: The Medtronic Bakken Invitation Award Honors 12 Patients from Around the World for Giving Back 48
6.4.4 Nov 05, 2015: Medtronic Releases 2015 Integrated Performance Report 48
6.5 Strategy And Business Planning 49
6.5.1 Jul 18, 2016: Proxy Biomedical Formally Announces Facility Expansion And Jobs Growth 49
6.5.2 Jan 11, 2016: Medtronic Updates Capital Allocation Plans and Fiscal 2016 EPS Guidance 49
7 Appendix 51
7.1 Research Methodology 52
7.1.1 Coverage 52
7.1.2 Secondary Research 52
7.1.3 Primary Research 53
7.1.4 Company Share Analysis 53
7.1.5 Distribution Share Analysis 53
7.1.6 Benchmarking 53
7.2 GlobalData Consulting 54
7.3 Contact Us 54
7.4 Disclaimer 55
Table 1: Orthobiologics Market, Ireland, Revenue ($m), USD Constant, Historic, 2008-2015 8
Table 2: Orthobiologics Market, Ireland, Revenue ($m), USD Constant, Forecast, 2015-2022 10
Table 3: Bone Grafts and Substitutes Market, Ireland, Revenue ($m), USD Constant, Historic, 2008-2015 12
Table 4: Bone Grafts and Substitutes Market, Ireland, Revenue ($m), USD Constant, Forecast, 2015-2022 14
Table 5: Orthobiologics Market, Ireland, Volume (Units), Historic, 2008-2015 16
Table 6: Orthobiologics Market, Ireland, Volume (Units), Forecast, 2015-2022 18
Table 7: Bone Grafts and Substitutes Market, Ireland, Volume (Units), Historic, 2008-2015 20
Table 8: Bone Grafts and Substitutes Market, Ireland, Volume (Units), Forecast, 2015-2022 22
Table 9: Orthobiologics Market, Ireland, Average Price ($), Historic, 2008-2015 23
Table 10: Orthobiologics Market, Ireland, Average Price ($), Forecast, 2015-2022 24
Table 11: Orthobiologics Market, Ireland, Average Price ($) Historic, 2008-2015 25
Table 12: Orthobiologics Market, Ireland, Average Price ($), Forecast, 2015-2022 26
Table 13: Orthobiologics Market, Ireland, Distribution Share by Revenue ($m), USD Constant, 2008-2022 27
Table 14: Orthobiologics Market, Ireland, Company Share by Revenue ($m), USD Constant, 2015 29
Table 15: Orthobiologics Market Pipeline Products 34
1.2 List of Figures
Figure 1: Orthobiologics Market, Ireland, Revenue ($m), USD Constant, Historic, 2008-2015 7
Figure 2: Orthobiologics Market, Ireland, Revenue ($m), USD Constant, Forecast, 2015-2022 9
Figure 3: Bone Grafts and Substitutes Market, Ireland, Revenue ($m), USD Constant, Historic, 2008-2015 11
Figure 4: Bone Grafts and Substitutes Market, Ireland, Revenue ($m), USD Constant, Forecast, 2015-2022 13
Figure 5: Orthobiologics Market, Ireland, Volume (Units), Historic, 2008-2015 15
Figure 6: Orthobiologics Market, Ireland, Volume (Units), Forecast, 2015-2022 17
Figure 7: Bone Grafts and Substitutes Market, Ireland, Volume (Units), Historic, 2008-2015 19
Figure 8: Bone Grafts and Substitutes Market, Ireland, Volume (Units), Forecast, 2015-2022 21
Figure 9: Orthobiologics Market, Ireland, Company Share (%) 2015 28
【免責事項】
https://www.marketreport.jp/reports-disclaimer